Kevin Fernando
@drkevinfernando
Portfolio GP, GPwER Diabetes/CVRM & Medical Education, Content Advisor @Medscape Global & UK, Honorary Clinical Reader @dundeeuni
#SGLT2is are therapeutic titans; however no drug is without harm Here are my #SGLT2i resources to help ensure benefits outweigh harms 🎯Patient-facing videos: youtube.com/@drkevinfernan… tiktok.com/@drkevinfernan… 🎯@GinP_Medscape Primary Care Hacks: medscape-uk.co/Hack-SGLT2i




IYASU Medical Bags are designer bags created for women in healthcare. Find your perfect style at iyasubags.com. Free global shipping. #IYASUMedicalBags #HealthcareFashion #MedicalStyle #DesignerBags #NurseFashion #DoctorStyle #HealthcareFashionista
As a NHS GP waist:height ratio measurement has now became an integral part of many consults. Being a GP means I manage the cascade of #CVRM long term conditions every day, so making room to manage the disease fueling the fires matters moving forwards #obesity #GeneralPractice
“In my practice I use waist height ratio in those with BMI below 35” @busetto_luca HT @ConscienHealth @AbdTahrani
My latest @Medscape Medical Mentor podcast is live! 🔶What is Lp(a), and when should we check it?🔶 🎯Lp(a) is an important but underappreciated independent risk factor for #ASCVD Link in comments👇🏾 Also on @Spotify & @ApplePodcasts
It has been so lovely to have the collaboration that @FamilyHeartFdn has with @endless_health for Lpa testing for free. I have patients and their families go here familyheart.org/ldl-and-lpa-sc… LDL and Lp(a) Screening - Family Heart Foundation
Thanks Kevin. Useful podcast. The challenge is that most labs will not allow ordering Lp(a) except by lipid specialists.
🌍 History in the Making – One World, One Vision! For the 1st time ever, #GHA1W Summit 2025 unites global health leaders to reimagine the future of healthcare. 📅 Nov 5–6 | 💻 Live Online Join the movement 👉 ghaoneworld.com #OneWorldSummit2025 #GHA2025 #GlobalHealth
🔶 Can #Orfoglipron #ACHIEVE The Unattainable?🔶 💡Another deep dive into practice-changing sessions from #ADA2025 scientific sessions, Chicago 🔥Key results and new insights from the #ACHIEVE trial and the evolving role #GLP1RA therapy in early #T2D 🔥 Link in comments 👇🏾

Registration is OPEN! Join us at the CVRMUK Autumn Conference 2025 📅 26 Nov | 🕣 08:30–16:55 | 📍 The King's Fund, London 🎟️ FREE to attend → cvrmukautumnconference2025.co.uk 🔬 Cardiovascular | Renal | Metabolic #CVRMUK2025 #MedTwitter #CardioTwitter #RenalHealth #MetabolicMedicine
I really liked Dr. DeFronzo's introduction, where he referred to the 'Big Four': difficult-to-control diabetes, resistant hypertension, osteoporosis/osteopenia, and increased visceral fat. He also introduced the concept of hypercortisolism as a contributing factor in the…
🚨 Game-changing GLP-1RA data drop! Largest NMA ever on #GLP1 in #T2D: 64 trials, 25K patients The rankings 🩸,⚖️: 🥇 Tirzepatide: -2.3% HbA1c, -10kg 🥈 Semaglutide: -1.5% HbA1c, -3.8kg 🥉 Liraglutide: -1.2% HbA1c, -2.1kg 💡 The twist: Safety profiles matter Sema & TZP⤴️…
🫀 CKD, CVD & diabetes are deeply connected – yet care is often fragmented. That’s why we launched CVRMUK: a new subspecialty to support HCPs with training, expert forums & resources across primary & secondary care. 📊 Join us & see our resources: 🔗cvrmuk.com/join